ABCA1 and chronic obstructive pulmonary disease: We have shown that LXR activation of ABCA1 does not promote the transcription of M2 genes in COPD macrophages, thus ruling out a potentially therapeutic role for LXR agonists in altering macrophage phenotype in COPD.